Silexion Therapeutics Corp Share Price

Silexion Therapeutics Corp Share Price

NASDAQ: SLXN | Micro Cap
$0.15
-$0.00 (-3.08%) Last updated on 30 Oct, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Silexion Therapeutics Corp Stock Performance

Open
$0.15
Prev. Close
$0.15
Circuit Range
N/A
Day Range
$0.15 - $0.16
Year Range
$0.15 - $5.02
Volume
1,425
Average Traded
$0.16

Silexion Therapeutics Corp Share Price Today

As of 30 October 2026, Silexion Therapeutics Corp's share price is $0.15. The stock opened at $0.15, compared to its previous close of $0.15. During today's trading session, Silexion Therapeutics Corp's share price traded between $0.15 and $0.16, with an average price of $0.16. Over the past 52 weeks, the stock has recorded a high of $5.02 and a low of $0.15. In terms of performance, Silexion Therapeutics Corp's share price has declined by 76.09% over the last six months and is down 95.52% on a year-on-year basis.

Silexion Therapeutics Corp Share Price Chart

Line chart of the Silexion Therapeutics Corp price trend over the selected period. The price fell overall, ranging from 0.15 to 0.16, ending at 0.15.
$0.15$0.16
L
Show Current Price
H

Silexion Therapeutics Corp Stock Fundamentals & Key Indicators

Market Cap
$196768.22
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Silexion Therapeutics Corp

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.

Silexion Therapeutics Corp Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.25
$0.15
-45.05%
Sep 2026
$0.37
$0.27
-22.22%
Aug 2026
$1.84
$0.35
-81.13%
Jul 2026
$2.66
$1.86
-25.90%
Jun 2026
$4.89
$2.51
-49.50%
May 2026
$0.59
$4.97
+702.91%
Apr 2026
$1.25
$0.62
-49.67%
Mar 2026
$1.68
$1.23
-28.70%
Feb 2026
$1.70
$1.73
-6.25%
Jan 2026
$2.18
$1.84
-7.07%
Dec 2025
$2.75
$1.98
-31.96%
Nov 2025
$3.25
$2.91
-11.82%

SLXN Share Price FAQs